Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
Clinical trial NCT02362451 · TERMINATED
Trial details
- NCT number
- NCT02362451
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-10
- Primary completion
- 2020-02-13
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.